Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Erick A. Argueta
Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment-Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Different Treatment Choice for First-Line Treatment of Helicobacter Pylori in an Area With a High Antibiotic Resistance
Turkish Journal of Gastroenterology
Gastroenterology
Clinical Efficacy of Gemifloxacin-Containing Triple Therapy for First-Line Treatment of Helicobacter Pylori Infection: A Pilot Study
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Efficacy of Potassium-Competitive Acid Blocker vs Proton Pump Inhibitor as First-Line and Second-Line Treatment for Helicobacter Pylori Eradication
Open Journal of Gastroenterology and Hepatology
Lactobacillus Reuteri – An Alternative in the First-Line of Helicobacter Pylori Eradication
Farmacia
Toxicology
Pharmaceutics
Pharmacology
14 Day-Sequential, Concomitant, and Hybrid Therapies for First-Line Helicobacter Pylori (H. PYLORI) Eradication: A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
First-Line Helicobacter Pylori Eradication in Patients With Chronic Kidney Diseases in Taiwan
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Treatment of Helicobacter Pylori Infection
Helicobacter
Medicine
Infectious Diseases
Gastroenterology